BEAM
Price
$22.94
Change
-$0.00 (-0.00%)
Updated
Oct 3 closing price
30 days until earnings call
MDXG
Price
$5.72
Change
-$0.00 (-0.00%)
Updated
Oct 3 closing price
25 days until earnings call
Ad is loading...

BEAM vs MDXG

Header iconBEAM vs MDXG Comparison
Open Charts BEAM vs MDXGBanner chart's image
Beam Therapeutics
Price$22.94
Change-$0.00 (-0.00%)
Volume$700.46K
CapitalizationN/A
MiMedx Group
Price$5.72
Change-$0.00 (-0.00%)
Volume$381.95K
CapitalizationN/A
View a ticker or compare two or three
BEAM vs MDXG Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MDXG
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
BEAM vs. MDXG commentary
Oct 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and MDXG is a StrongBuy.

COMPARISON
Comparison
Oct 05, 2024
Stock price -- (BEAM: $22.94 vs. MDXG: $5.72)
Brand notoriety: BEAM and MDXG are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 90% vs. MDXG: 55%
Market capitalization -- BEAM: $2.06B vs. MDXG: $867.64M
BEAM [@Biotechnology] is valued at $2.06B. MDXG’s [@Biotechnology] market capitalization is $867.64M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileMDXG’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • MDXG’s FA Score: 1 green, 4 red.
According to our system of comparison, both BEAM and MDXG are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 3 TA indicator(s) are bullish while MDXG’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 3 bullish, 4 bearish.
  • MDXG’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, MDXG is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а -8.68% price change this week, while MDXG (@Biotechnology) price change was +1.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.51%. For the same industry, the average monthly price growth was +3.11%, and the average quarterly price growth was -5.53%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 04, 2024.

MDXG is expected to report earnings on Oct 29, 2024.

Industries' Descriptions

@Biotechnology (+3.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.07B) has a higher market cap than MDXG($868M). BEAM YTD gains are higher at: -15.724 vs. MDXG (-34.778). MDXG has higher annual earnings (EBITDA): 66.8M vs. BEAM (-162.88M). BEAM has more cash in the bank: 1.01B vs. MDXG (69M). MDXG has less debt than BEAM: MDXG (19.2M) vs BEAM (165M). BEAM (353M) and MDXG (340M) have equivalent revenues.
BEAMMDXGBEAM / MDXG
Capitalization2.07B868M238%
EBITDA-162.88M66.8M-244%
Gain YTD-15.724-34.77845%
P/E RatioN/A10.37-
Revenue353M340M104%
Total Cash1.01B69M1,461%
Total Debt165M19.2M859%
FUNDAMENTALS RATINGS
MDXG: Fundamental Ratings
MDXG
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
PROFIT vs RISK RATING
1..100
92
SMR RATING
1..100
12
PRICE GROWTH RATING
1..100
82
P/E GROWTH RATING
1..100
92
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMMDXG
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 22 days ago
81%
Bullish Trend 5 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 2 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MDXG
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ESSIX15.17-0.02
-0.13%
Essential 40 Stock I
RNGEX64.03-0.11
-0.17%
American Funds New Economy R4
CRRRX16.68-0.06
-0.36%
Columbia Small Cap Value II Inst2
PICRX42.26-0.24
-0.56%
Putnam International Capital Opp R
BIRDX10.35-0.09
-0.86%
iShares Developed Real Estate Idx Instl

MDXG and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDXG has been loosely correlated with NTLA. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if MDXG jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDXG
1D Price
Change %
MDXG100%
-1.38%
NTLA - MDXG
52%
Loosely correlated
-4.85%
RCKT - MDXG
50%
Loosely correlated
-5.31%
VCEL - MDXG
50%
Loosely correlated
+1.60%
BEAM - MDXG
49%
Loosely correlated
-2.38%
RXRX - MDXG
49%
Loosely correlated
-0.82%
More